Han-Joo Kim

Han-Joo Kim


Job title: Chief Executive Officer


Workshop A: Next-Generation Blood-Brain Barrier Penetrant Therapeutic Antibodies 8:00 am

The recent approval of anti-Aβ antibodies has ushered in new possibilities and challenges in the realm of neurodegenerative diseases. A significant hurdle lies in the blood-brain barrier, permitting only 0.01-0.1% of antibodies to traverse into the brain, primarily through cerebrospinal fluid. The pivotal and complex challenge of achieving selective delivery of therapeutic antibodies with high…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.